Published in PLoS One on December 05, 2013
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet (1996) 26.06
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med (2008) 5.43
The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem (1997) 2.62
Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet (1997) 2.53
EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol (2010) 2.13
Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A (1997) 2.03
Hemochromatosis: an endocrine liver disease. Hepatology (2007) 1.96
EASL International Consensus Conference on Haemochromatosis. J Hepatol (2000) 1.76
The molecular genetics of haemochromatosis. Eur J Hum Genet (2005) 1.26
Monitoring the obesity epidemic in France: the Obepi surveys 1997-2006. Obesity (Silver Spring) (2008) 1.24
HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology (2009) 1.07
Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol (2003) 1.05
Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants. Ann Hematol (2009) 1.00
Factors influencing disease phenotype and penetrance in HFE haemochromatosis. Hum Genet (2010) 0.97
The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clin Gastroenterol Hepatol (2006) 0.97
Clinical penetrance of hereditary hemochromatosis. N Engl J Med (2008) 0.92
Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants. Haematologica (2011) 0.90
Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain. Ann Hematol (2010) 0.86
Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis? Ann Genet (1998) 0.85
Haemochromatosis, HFE and genetic complexity. Nat Genet (1997) 0.85
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes. Blood Cells Mol Dis (2010) 0.82
Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data. BMC Med Genet (2005) 0.80
[Hyperferritinemia not related to hemochromatosis]. Gastroenterol Clin Biol (2009) 0.78
Gene conversion: mechanisms, evolution and human disease. Nat Rev Genet (2007) 4.62
Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol (2013) 2.85
Hereditary pancreatitis caused by triplication of the trypsinogen locus. Nat Genet (2006) 2.44
Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet (2013) 2.10
A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum Genet (2005) 2.10
Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet (2008) 1.94
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet (2006) 1.90
European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros (2009) 1.75
Meta-analysis of gross insertions causing human genetic disease: novel mutational mechanisms and the role of replication slippage. Hum Mutat (2005) 1.74
Genomic rearrangements in inherited disease and cancer. Semin Cancer Biol (2010) 1.72
Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Hum Mutat (2009) 1.71
Homozygous deletion of HFE produces a phenotype similar to the HFE p.C282Y/p.C282Y genotype. Blood (2008) 1.66
Gene conversion causing human inherited disease: evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair. Hum Mutat (2009) 1.64
ABL1 fusion genes in hematological malignancies: a review. Eur J Haematol (2011) 1.61
A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet (2006) 1.55
Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum Mutat (2004) 1.54
On the sequence-directed nature of human gene mutation: the role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease. Hum Mutat (2011) 1.53
HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood (2003) 1.52
Chronic pancreatitis: genetics and pathogenesis. Annu Rev Genomics Hum Genet (2009) 1.46
Phenotypic expression of the C282Y/Q283P compound heterozygosity in HFE and molecular modeling of the Q283P mutation effect. Blood Cells Mol Dis (2003) 1.45
Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat (2012) 1.45
Complex gene rearrangements caused by serial replication slippage. Hum Mutat (2005) 1.41
Intrachromosomal serial replication slippage in trans gives rise to diverse genomic rearrangements involving inversions. Hum Mutat (2005) 1.37
Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet (2007) 1.33
Trypsinogen copy number mutations in patients with idiopathic chronic pancreatitis. Clin Gastroenterol Hepatol (2007) 1.32
Evolution of trypsinogen activation peptides. Mol Biol Evol (2003) 1.31
Cell-autonomous roles of ARX in cell proliferation and neuronal migration during corticogenesis. J Neurosci (2008) 1.28
Closely spaced multiple mutations as potential signatures of transient hypermutability in human genes. Hum Mutat (2009) 1.28
The molecular genetics of haemochromatosis. Eur J Hum Genet (2005) 1.26
Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol (2008) 1.22
Time trends in birth incidence of cystic fibrosis in two European areas: data from newborn screening programs. J Pediatr (2007) 1.19
Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis. Hum Mutat (2007) 1.17
Double complex mutations involving F8 and FUNDC2 caused by distinct break-induced replication. Hum Mutat (2007) 1.15
Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995. Gastroenterol Clin Biol (2005) 1.14
Genetics of osteoporosis: accelerating pace in gene identification and validation. Hum Genet (2009) 1.14
RUNX1 translocations and fusion genes in malignant hemopathies. Future Oncol (2011) 1.14
Coupling cystic fibrosis to endoplasmic reticulum stress: Differential role of Grp78 and ATF6. Biochim Biophys Acta (2007) 1.10
Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients. J Med Virol (2005) 1.08
The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet (2004) 1.05
Genetics and pathogenesis of chronic pancreatitis: the 2012 update. Clin Res Hepatol Gastroenterol (2012) 1.05
Transient hypermutability, chromothripsis and replication-based mechanisms in the generation of concurrent clustered mutations. Mutat Res (2012) 1.05
Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol (2003) 1.05
Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum (2006) 1.03
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy. J Med Virol (2009) 1.02
Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2). Hum Mutat (2004) 1.00
A missense mutation in the alpha-actinin 1 gene (ACTN1) is the cause of autosomal dominant macrothrombocytopenia in a large French family. PLoS One (2013) 0.98
Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation. Hum Genet (2008) 0.98
Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis. Hum Genet (2007) 0.98
The potential of oligonucleotides for therapeutic applications. Trends Biotechnol (2006) 0.98
LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease: mutation detection bias and multiple mechanisms of target gene disruption. J Biomed Biotechnol (2006) 0.94
A new and more accurate estimate of the rate of concurrent tandem-base substitution mutations in the human germline: ∼0.4% of the single-nucleotide substitution mutation rate. Hum Mutat (2014) 0.93
Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study. J Clin Gastroenterol (2005) 0.93
Detection of a large genomic deletion in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet (2006) 0.93
Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels? Pediatrics (2006) 0.91
A large genomic deletion in the PDHX gene caused by the retrotranspositional insertion of a full-length LINE-1 element. Hum Mutat (2007) 0.91
Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on. Hum Mutat (2014) 0.91
A new large deletion in the DFNB1 locus causes nonsyndromic hearing loss. Eur J Med Genet (2008) 0.90
Complete ascertainment of intragenic copy number mutations (CNMs) in the CFTR gene and its implications for CNM formation at other autosomal loci. Hum Mutat (2010) 0.90
Prevalence and topography of intestinal metaplasia in columnar lined esophagus. Gastroenterol Clin Biol (2007) 0.89
High-throughput analysis of promoter occupancy reveals new targets for Arx, a gene mutated in mental retardation and interneuronopathies. PLoS One (2011) 0.89
Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory. Mol Oncol (2011) 0.89
The calpain, caspase 12, caspase 3 cascade leading to apoptosis is altered in F508del-CFTR expressing cells. PLoS One (2009) 0.88
Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients. Gastroenterol Clin Biol (2004) 0.88
Endometrial vascularity and ongoing pregnancy after IVF. Eur J Obstet Gynecol Reprod Biol (2002) 0.88
Juvenile hemochromatosis locus maps to chromosome 1q in a French Canadian population. Eur J Hum Genet (2003) 0.88
Co-inheritance of a novel deletion of the entire SPINK1 gene with a CFTR missense mutation (L997F) in a family with chronic pancreatitis. Mol Genet Metab (2007) 0.87
Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH. J Neurooncol (2012) 0.87
Patterns and mutational signatures of tandem base substitutions causing human inherited disease. Hum Mutat (2013) 0.86
Focus on cystic fibrosis and other disorders evidenced in fetuses with sonographic finding of echogenic bowel: 16-year report from Brittany, France. Am J Obstet Gynecol (2010) 0.86
Next-generation sequencing is a credible strategy for blood group genotyping. Br J Haematol (2014) 0.85